bioMérieux Investor Relations Material

bioMérieux S.A. is a worldwide leader in the manufacture, marketing, and distribution of in vitro diagnostics for human and animal health applications. With sales that exceeded €1 billion for the first time in 2016, bioMérieux offers close to 20,000 products marketed under the brand names of ELITechGroup Pharma-Vet, bioMérieux Analyzer, molecular subsidiaries TA Systems and RED-BioSys Medical Insurance Company; Immedica, a provider of managed clinical care programs; BioFire Defense LLC (a wholly owned subsidiary), an integrated forensic product line; BD and Embletta which are joint ventures with Becton Dickinson & Company and Synlab Holding S.r.l., respectively; AxioMed Life Technologies Inc., a US company owning the patents associated with knee joint replacement implants Actifuse Foot Fusion System (AFFS) and same named prostheses; and Emmesure Inc., launched in 2013 to develop enhanced solutions for clinical laboratories through collaborations with small companies.